Israel began administering a third shot of the Pfizer/BioNTech vaccine to patients with compromised immune systems. With cases rising in the country, those eligible for a third shot include those who have had heart, lung and kidney transplants as well as cancer patients. The health ministry stated that patients with immunosuppression do not develop the adequate antibody response after the normal two doses. The decision was further supported given the rising daily infection tally.
Israel had one of the fastest rollouts of the Pfizer/BioNTech vaccines in the world, succeeding in bringing daily cases down to single digits just last month. The Delta variant changed everything, as Israel had already fully vaccinated 85% of its adult population and restoring indoor dining and allowing large gatherings. The variant led to huge surges, prompting the booster dose to be administered.
#MaltaDaily
Photo Source: CNBC